This financial success underscores radioligand therapeutics' immense commercial and therapeutic potential, signalling their emergence as a pillar of modern oncology. With proof-of-concept ...

Johnson & Johnson’s investment includes the construction of a $2 billion-plus biologics facility in North Carolina.

This comprehensive review analyzes cutting-edge tools and technologies in modern pharmaceutical research, focusing on ...

Everhope Oncology, a joint venture between Narayana Health and a venture capital firm, has secured $10 million in seed ...

The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.

The new center is expected to offer more modern medical technology in addition to improved access and patient experience.

Small-Cap Firms Dominate Market Rally. In this article, we are going to take a look at where ALX Oncology Holdings Inc. (NASDAQ:ALXO) stands against the other stocks. The stock market pulled back to ...

With an initial USD 10 million seed funding, Everhope will establish medical and surgical oncology facilities in Delhi and Mumbai, with plans to expand to 10 cities over the next three years.

Until recently, the treatment of metastatic castration-resistant prostate cancer (mCRPC) relied exclusively on hormonal therapies and taxane chemotherapy. The advent of modern molecular profiling ...